Support Telecomtalk
Andrew Bonwick
Vice President of Product Development at Relm Insurance
Madhav Sheth
CEO of Ai+ Smartphone
Stephen Rose
CEO Render Networks
Gilat Satellite Networks (Gilat) announced that its wholly owned US-based subsidiary, DataPath, has received contracts in support of the US Department of Defense for core terminal-related services, technology insertion, and upgrades to systems, cumulatively worth over USD 5 million.
- Make Telecom Talk My Trusted Source
Also Read: Gilat Satellite Networks Secures USD 12 Million Expansion Deal
Enhancing Satellite Transportable Terminals
DataPath is tasked with the sustainment and technical upgrades of multiple Satellite Transportable Terminal (STT) units to enhance these critical assets and the effectiveness of military operations, Gilat said Monday.
Commenting on the contracts, DataPath said, “We are dedicated to delivering solutions that enhance the capabilities and reliability of military communications and to supplying the latest technology upgrades and updates. These contracts reinforce our commitment to supporting our armed forces and advancing national security.”
Also Read: Intelsat to Offer Multi-Orbit Solutions Across Business Units by Mid-2025
Upgrading Satellite Communications Equipment
In addition, DataPath will undertake upgrades to existing satellite communications equipment to both enhance the capabilities of these systems and make them leaner and more efficient for the men and women in uniform to operate.
Every article you read here is the result of time, research, and effort. If you feel it adds value, you can support TelecomTalk.
Motorola Signature 27 Is Coming to India: 5 Things to Watch
Hyderabad Startup Builds Robot With Humanlike Hands
Vodafone
Bharti Airtel Adds 9,803 Route Km of Optical Fibre in Three Months
Ericsson and HBL Integrate Kavach 4.0 With 5G in Hyderabad Lab
Airtel Mobile ARPU Rises to Rs 271 as Postpaid Additions Hit a Record
OnePlus ColorOS 17 November Rollout: Eligible Phone List Out
Vivo X500 Series India Launch Confirmed
